RW-BP100-2D

General Information


DRACP ID  DRACP04629

Peptide Name   RW-BP100-2D

Sequence  RrLFRRILRWL

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C68H111N23O10

Absent amino acids  ACDEGHKMNPQSTVY

Common amino acids  R

Mass  158932

Pl  12.98

Basic residues  4

Acidic residues  0

Hydrophobic residues  6

Net charge  4

Boman Index  -3469

Hydrophobicity  -1.82

Aliphatic Index  141.82

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  550

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35145500

Title  RW-BP100-4D, a Promising Antimicrobial Candidate With Broad-Spectrum Bactericidal Activity

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20741

DRACP is developed by Dr.Zheng's team.